Dr Reddy’s gets VAI status from US FDA for its two facilities
Dr Reddy’s R&D centre which is the Integrated Product Development Organisation (IPDO) located at Bachupally, Hyderabad, underwent a GMP and Pre-Approval Inspection (PAI) by the US FDA in December 2023. The US FDA has now classified that inspection too as Voluntary Action Indicated (VAI).
Big achievement
This is the second piece of good news in recent days. On February 10, the company stated that it had updated that the US FDA had issued VAI status to FTO-3, our largest formulations manufacturing plant also in Bachupally and concluded the inspection as closed, stated the Hyderabad-based pharma major.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!